Document Detail


Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
MedLine Citation:
PMID:  20200547     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
A prespecified subgroup analysis of a 44-week open-label extension study is presented. The efficacy and safety of the combination of amlodipine (AML) + olmesartan medoxomil (OM), with and without the addition of hydrochlorothiazide (HCTZ), were investigated in patients aged ≥65 and <65 years, Blacks and non-Blacks and patients with and without type 2 diabetes. After an 8-week double-blind, placebo-controlled portion of the study, patients initiated therapy on AML 5 + OM 40 mg per day, were uptitrated stepwise to AML 10 + OM 40 mg per day, with the addition of HCTZ 12.5 mg, and 25 mg if blood pressure (BP) goal was not achieved (<140/90 or <130/80 mm Hg for patients with diabetes). Endpoints included the change from baseline in mean seated systolic BP, mean seated diastolic BP and achievement of BP goal. BP decreased from baseline for all treatments in each prespecified subgroup. By the end of the study, BP goal was achieved in 61.0% of patients aged ≥65 years, 68.1% of patients aged <65 years, 63.3% of Blacks, 67.8% of non-Blacks, 26.9% of patients with diabetes and 72.9% of patients without diabetes. The combination of AML + OM ± HCTZ was efficacious, safe and well tolerated by these subgroups.
Authors:
S Oparil; S G Chrysant; M Melino; J Lee; S Karki; R Heyrman
Related Documents :
1482747 - Insulin resistance, hyperinsulinemia, and obesity-associated hypertension.
2043227 - Metabolic adverse effects of thiazide diuretics: the importance of normokalaemia.
10678547 - Insulin levels during fasting and the glucose tolerance test and homa's index predict s...
9251947 - Hypertensive disorders in pregnant women with diabetes mellitus.
18460557 - Comparison of single and combined treatment with exenatide and metformin on menstrual c...
10956447 - Maternal diabetes and neonatal outcome.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-03-04
Journal Detail:
Title:  Journal of human hypertension     Volume:  24     ISSN:  1476-5527     ISO Abbreviation:  J Hum Hypertens     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8811625     Medline TA:  J Hum Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  831-8     Citation Subset:  IM    
Affiliation:
Division of Cardiovascular Diseases, University of Alabama at Birmingham School of Medicine, Birmingham, AL 35294-0007, USA. soparil@uab.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Finemapping of the arthritis QTL Pia7 reveals co-localization with Oia2 and the APLEC locus.
Next Document:  Regular slow-breathing exercise effects on blood pressure and breathing patterns at rest.